Dolorex

Dolorex

Dolorex Recall

Get an alert when a recall is issued.

Questions & Answers

Side Effects & Adverse Reactions

FOR USE IN HORSES ONLY. NOT FOR USE IN HORSES INTENDED FOR HUMAN CONSUMPTION.

Legal Issues

There is currently no legal information available for this drug.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

DOLOREX (butorphanol tartrate) is indicated for the relief of pain associated with colic in adult horses and yearlings. Clinical studies in the horse have shown that butorphanol tartrate alleviates abdominal pain associated with torsion, impaction, intussusception, spasmodic and tympanic colic, and postpartum pain.

History

There is currently no drug history available for this drug.

Other Information

DOLOREX (butorphanol tartrate) is a totally synthetic, centrally acting, narcotic agonist-antagonist analgesic with potent antitussive activity. It is a member of the phenanthrene series. The chemical name is Morphinan-3, 14-diol, 17-(cyclobutylmethyl)-, (-)-, (S- (R*, R*))- 2, 3- dihydroxybutanedioate (1:1) (salt). It is a white crystalline, water soluble substance having a molecular weight of 477.55; its molecular formula is C21H29NO2 C4H6O6.

Chemical Structure

Each mL of DOLOREX contains 10 mg butorphanol base (as butorphanol tartrate, USP), 3.3 mg citric acid, Ph.Eur., 6.4 mg sodium citrate, Ph.Eur., 4.7 mg sodium chloride, Ph.Eur., and 0.1 mg benzethonium chloride, Ph.Eur., q.s. with water for injection, Ph.Eur.

Dolorex Manufacturers


  • Merck Sharp & Dohme Corp.
    Dolorex (Butorphanol Tartrate) Injection [Merck Sharp & Dohme Corp.]

Login To Your Free Account